Case File
efta-efta00938712DOJ Data Set 9OtherFrom: Jeffrey Epstein <[email protected]>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00938712
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey Epstein <[email protected]>
To: Eileen Alexanderson
, Melanie Spinella
Subject:
Date: Fri, 06 Jul 2012 03:17:56 +0000
The IRS has advanced many theories to challenge the gift and estate tax savings occasioned by the use of family
entities and grantor trusts in estate planning. Until recently, most IRS arguments had been rather unsuccessful.
However, the IRS discovered a potent weapon in IRC § 2036(a), which provides that the value of the gross estate
includes the value of all property to the extent the decedent has made a transfer but has retained (i) the
possession or enjoyment of, or the right to income from, the property, or (ii) the right, either alone or in
conjunction with any person, to designate the persons who shall possess or enjoy the property or the income
therefrom.
The IRS has been successful in arguing that IRC § 2036(a) requires the inclusion in the decedent's estate of (i)
partnership assets if the decedent continued to derive benefits from the partnership, or of (ii) trust assets, if the
decedent continued to receive distributions, disguised in the form of a note, from assets sold to a "defective"
grantor trust. The IRS has been most successful where the transactions with not imbued with a sufficient
quantum of non-tax objectives, or the economics of the transaction were questionable, most often because the
grantor had not left himself with sufficient assets to live according to his accustomed standard without receiving
partnership (or trust) distributions.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation®gmail.com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00938712
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
OtherUnknown
FEDWIRE PAYMENT DEBIT ADVICE
DOJ EFTA Data Set 10 document EFTA01273102
16p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.